Skip to main content
Veterinary Medicines

Kanacef M.C. Intramammary Suspension

Authorised
  • Cefalexin monohydrate
  • KANAMYCIN MONOSULPHATE

Product identification

Medicine name:
Kanacef M.C. Intramammary Suspension
Active substance:
  • Cefalexin monohydrate
  • KANAMYCIN MONOSULPHATE
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Cefalexin monohydrate
    210.36
    milligram(s)
    /
    1.00
    Syringe
  • KANAMYCIN MONOSULPHATE
    100000.00
    international unit(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        7
        day
      • Milk
        108
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RD01
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Historical pack size: A white 10 g LPDE intramammary syringe (12 ml) comprising of barrel, plunger and a blue sealed sterile tip (cap). 10 tubes per carton.
  • A white 10 g LPDE intramammary syringe (12 ml) comprising of barrel, plunger and a blue sealed sterile tip (cap). 10 tubes per carton.
  • A white 10 g LPDE intramammary syringe (12 ml) comprising of barrel, plunger and a blue sealed sterile tip (cap).20 tubes per carton.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Interchem (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Interchem (Ireland) Limited
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10555/001/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download